You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development and Preclinical Testing of the TORVAD Ventricular Assist System in Preparation for First in Human Implantation
SBC: WINDMILL CARDIOVASCULAR Topic: NHLBIDESCRIPTIONprovided by applicantThe TORVAD tmis a unique ventricular assist system that delivers low shearsynchronouspulsatile flowBlood shear due to pumping is minimized by the relatively low speed of pistons supported by hydrodynamic bearings designed to maintain a fixed gap between the piston and torus wallsThe TORVAD synchronizes with the heart to preserve aortic valve flow and maintains autor ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development and Preclinical Testing of the TORVAD Ventricular Assist System in Preparation for First in Human Implantation
SBC: WINDMILL CARDIOVASCULAR Topic: NHLBIDESCRIPTIONprovided by applicantThe TORVAD tmis a unique ventricular assist system that delivers low shearsynchronouspulsatile flowBlood shear due to pumping is minimized by the relatively low speed of pistons supported by hydrodynamic bearings designed to maintain a fixed gap between the piston and torus wallsThe TORVAD synchronizes with the heart to preserve aortic valve flow and maintains autor ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure
SBC: Chrysalis BioTherapeutics, Inc. Topic: NIAIDDESCRIPTIONprovided by applicantWith increasing risk of a nuclear accident or detonationthere is a critical need to develop effective medicinal countermeasures that can be delivered to victims after an incident to increase survival and prevent long term effects in those that surviveMajor causes of death following a nuclear incident include acute radiation syndromesARSthat destroy hematopoietic ste ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a Biochemical Diagnosis for Creutzfeldt Jakob disease
SBC: Amprion, Inc. Topic: 101ABSTRACT Human prion diseases are infectious and invariably fatal neurodegenerative diseases including sporadic Creutzfeldt Jakob disease sCJD the most common form and variant CJD vCJD which is associated to consumption of cattle meat infected by bovine spongiform encephalopathy Currently there is not sensitive objective and non invasive biochemical diagnosis for these diseases and even ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a Biochemical Diagnosis for Creutzfeldt Jakob disease
SBC: Amprion, Inc. Topic: 101ABSTRACT Human prion diseases are infectious and invariably fatal neurodegenerative diseases including sporadic Creutzfeldt Jakob disease sCJD the most common form and variant CJD vCJD which is associated to consumption of cattle meat infected by bovine spongiform encephalopathy Currently there is not sensitive objective and non invasive biochemical diagnosis for these diseases and even ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Monoclonal Antibodies to Treat Pancreatic Cancer
SBC: COARE BIOTECHNOLOGY, INC. Topic: NCIAbstract Pancreatic ductal adenocarcinoma PDAC is a devastating cancer with an extremely low year survival rate even for those who are diagnosed early Novel research suggests that this may be the result of metastatic dissemination preceding or concurrent to the development of the primary tumor Epithelial mesenchymal transition EMT is one of the key pathways in pancreatic cancer invasion ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Innovative Optical System for Hemagglutination Assays
SBC: INDEVR, INC. Topic: NIAIDPROJECT SUMMARY The Hemagglutination assay HA and Hemagglutination Inhibition HI assay are widely used methods for characterizing viruses bacteria and antibodies The World Health Organization recently recommended that HI remain the gold standard method for influenza seroepidemiology Although the HA and HI assays are applied worldwide they have the disadvantages of manual plate reading no ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Novel DFG out inhibitors of Abl-kinases to treat PML
SBC: Inhibikase Therapeutics, Inc. Topic: NIAIDDESCRIPTION provided by applicant Inhibikase Therapeutics is a clinical stage biopharmaceutical company that has developed a host targeted mechanism of action to treat AIDS related and drug induced progressive multifocal leukoencephalopathy PML PML is a demyelinating disease of the central nervous system and was rarely seen clinically until the era of the HIV epidemic began in the mid s During the ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
CSI Glucagon for Treatment of Congenital Hyperinsulinism
SBC: Xeris Pharmaceuticals, Inc. Topic: 200DESCRIPTION provided by applicant The objective of this program is to further the development of a novel stable non aqueous glucagon formulation CSI continuous subcutaneous infused Glucagon tm in combination with a Insulet OmniPod r infusion pump for prevention of hypoglycemia in patients with congenital hyperinsulinism HI The addition of glucagon will meet a significant unmet need i ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Intervening to Prevent Youth Access to Marijuana Phase II
SBC: KLEIN BUENDEL, INC. Topic: NIDADESCRIPTION provided by applicant The legalization of marijuana in Alaska Colorado Oregon and Washington is the most dramatic change in U S substance abuse policy since the end of Prohibition These states are implementing regulatory and enforcement systems for the retail sales of recreational marijuana to adults years or older akin to state controls on the sale of alcohol In the ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health